Beverage and Snack operations continue to deliver growth and
improved margin as Value Creation Plan transitions into the second phase
of the operational turnaround
TORONTO--(BUSINESS WIRE)--Aug. 8, 2018--
SunOpta Inc. (“SunOpta” or the “Company”) (Nasdaq:STKL) (TSX:SOY), a
leading global company focused on organic, non-genetically modified and
specialty foods, today announced financial results for the second
quarter ended June 30, 2018.
“We continued to make progress under each of the four pillars of the
Value Creation Plan and have largely transitioned into the second phase
of our operational turnaround. We are converting our sales opportunity
pipeline and, based on the wins to date, anticipate delivering
meaningful revenue growth during the second half of 2018,” said David
Colo, Chief Executive Officer. “During the second quarter, our beverage
and snack platforms continued to deliver revenue growth and improved
margin, reflecting our revitalized commercialization efforts over the
last 18 months. We also continued to see demand for organic ingredients
grow and we remain committed to our strategic focus that is designed to
leverage structural advantages in Global Ingredients, despite some
timing-related foreign exchange and commodity items that impacted gross
margin in the quarter. While challenges remain in our Healthy Fruit
business, year-over-year revenue declines moderated during the second
quarter, and we made progress on our improvement plan, which includes
re-balancing our frozen inventories and improving our productivity. We
remain intensely focused on optimizing our production costs while
continuing to make the necessary investments in food safety, quality,
and innovation to return this business to profitable growth. We are on
track to deliver $20 million of productivity-driven EBITDA improvements
this year; however, these improvements are expected to be offset by
pricing investments and increased operational costs in Healthy Fruit,
that we are addressing as part of the improvement plan.”
All amounts are expressed in U.S. dollars and results are reported in
accordance with U.S. GAAP, except where specifically noted.
Second Quarter 2018 Highlights:
-
Revenues of $319.3 million for the second quarter of 2018, compared to
$336.5 million in the second quarter of 2017, a decrease of 5.1%.
Adjusted for changes in foreign exchange, commodity prices, and sales
of flexible resealable pouch and nutrition bar products, revenues
declined 0.6% during the second quarter.
-
Loss attributable to common shareholders of $5.1 million or $0.06 per
common share in the second quarter of 2018, compared to a loss
attributable to common shareholders of $2.4 million or $0.03 per
common share in the second quarter of 2017.
-
Adjusted loss¹ of $5.0 million or $0.06 per common share during the
second quarter of 2018, compared to adjusted loss¹ of $0.7 million or
$0.01 per common share during the second quarter of 2017.
-
Adjusted EBITDA¹ of $14.8 million or 4.6% of revenues for the second
quarter of 2018, versus $19.4 million or 5.8% of revenues in the
second quarter of 2017.
-
Loss attributable to common shareholders, Adjusted loss¹ and Adjusted
EBITDA¹ for the second quarter of 2018 included a timing-related,
pre-tax charge of $2.5 million recognized in cost of goods sold,
relating to the net impact of significant foreign exchange and
commodity price movements in the quarter, on certain contracts within
the European-based operations of the Global Ingredients segment.
¹ See discussion of non-GAAP measures included at the end of this press
release
Value Creation Plan Update
As part of the Company’s commitment to deliver long-term value to its
shareholders, in early 2017 it launched its Value Creation Plan. The
Company is targeting implementation of $30 million of
productivity-driven annualized enhancements to EBITDA in the first phase
of the plan, to be implemented over 2017 and 2018. For 2017, these
EBITDA benefits were offset by expenses associated with the Value
Creation Plan, including structural investments made in the areas of
quality, sales, marketing, operations and engineering resources, as well
as non-structural third-party consulting support, severance and
recruiting costs. The plan also calls for increased investment in
capital upgrades at several manufacturing facilities to enhance food
safety and manufacturing efficiencies. Over time, these investments are
expected to yield additional improvement in EBITDA beyond the $30
million of initial productivity-driven savings. During the second
quarter of 2018, the Company continued to make progress against each of
the four pillars of its Value Creation Plan and believes it is on track
to achieve targeted productivity enhancements, while continuing to make
the necessary structural investments it believes will accelerate growth
and drive long-term value. Since the initiation of the Value Creation
Plan, the Company has implemented actions that are expected to yield
approximately $23 million of annualized EBITDA benefits.
Recent progress on each of the four pillars of the Value Creation Plan
is highlighted below.
Portfolio Optimization
The focus of the portfolio optimization pillar is to simplify the
business, investing where structural advantages exist, while exiting
businesses or product lines where the Company is not effectively
positioned. Recent highlights include:
-
Initiated plans to expand aseptic processing and packaging capacity
and capabilities at the Allentown, Pennsylvania, beverage facility,
based on current growth trends and recent business wins in both the
non-dairy and broth categories. This expansion is expected to cost
approximately $22 million and come on-line in mid-2019. The investment
is designed to add enhanced mixing and processing capabilities which
will enable the Company to bring further innovation to the plant-based
beverage market. As part of the expansion, additional processing and
filling capacity will be added, which is expected to provide increased
flexibility and cost advantages across the national network of aseptic
plants, while creating needed capacity to continue to grow with
organic and conventional broth offerings.
-
Advanced commercial production on the second roasting and processing
line at the Company’s organic cocoa facility in the Netherlands.
During the quarter, the facility realized yields in-line with
expectation and throughput at 80% of designed capacity. The expansion
is expected to reach its designed run-rate by the end of the third
quarter. This expansion approximately doubles cocoa processing
capacity in addition to adding new capabilities at the facility.
-
Continued commissioning of new roasting equipment at the Company’s
Crookston, Minnesota, facility. The new equipment is designed to
increase production efficiencies and add incremental capacity and
roasting capabilities following the closure and consolidation of a
roasted snack plant in Wahpeton, North Dakota. Certain roasting
capabilities are now on-line, and full commissioning is expected to be
completed in the fourth quarter. This initiative is expected to
support further growth in the healthy snacks portfolio serving demand
for on-trend roasted grains, seeds and legumes.
-
Continued commissioning efforts on a new oil processing line at the
Company’s Bulgarian sunflower facility, which is expected to drive
incremental margins through growth and production efficiency.
Operational Excellence
The focus of the operational excellence pillar is to ensure food quality
and safety, coupled with improved operational performance and
efficiency. The Company expects these efforts to generate productivity
improvements and cost savings in manufacturing, procurement and
logistics. Recent highlights include:
-
Continued strong operational performance across the network of aseptic
facilities. The Company expects overall capacity utilization to be
approximately 85% by the end of 2018, versus approximately 70% in the
second quarter.
-
Completed approximately 90% of the 2018 fruit pack season at targeted
fruit recovery rates, and recently implemented sorting and handling
enhancements designed to drive improved fruit quality.
-
Continued advancement of food safety and quality efforts across the
entire manufacturing footprint. Third-party audit scores are trending
positively versus the prior year, and consumer complaints in the
Healthy Fruit platform are almost one-third lower than prior year.
-
Continued to identify productivity opportunities through the SunOpta
360 continuous improvement initiative in the areas of
manufacturing, purchasing and supply chain management.
Go-To-Market Effectiveness
The focus of the go-to-market effectiveness pillar is to optimize
customer and product mix in existing sales channels, and identify and
penetrate new high-potential sales channels. The Company expects efforts
under this pillar to improve revenue growth and profitability over time.
Recent highlights include:
-
The pipeline of commercial opportunities in Consumer Products remains
strong and the overall contract book for organic ingredients both in
Europe and the U.S. exceeds prior year levels.
-
Recent commercial wins include additional private label broth into the
traditional and specialty retail channels, expanded distribution and
additional SKUs of frozen fruit into the mass and grocery channels,
secured incremental frozen fruit offerings servicing the foodservice
channel that are expected to ship in the fourth quarter, and increased
sales of co-manufactured fruit snacks that are expected to ship in the
third quarter.
-
Further progress on commercialization of approximately 100 new
everyday broth and frozen fruit SKUs with large mass and traditional
retailers.
Process Sustainability
The focus of the process sustainability pillar is to ensure the Company
has the infrastructure, systems and skills to sustain the business
improvements and value captured from the Value Creation Plan. Broadening
the skillset and experience of SunOpta’s leadership team is a critical
component to the process sustainability pillar of the Value Creation
Plan. Recent highlights include:
-
Implementation of a new specification system for ingredients which is
designed to drive improved food safety and quality in addition to
improved research and development efficiencies.
-
Enhancements to employee health and safety processes continued to
result in a reduction in recordable incidents year-to-date in 2018
compared to 2017.
-
Advanced aseptic capacity planning model capabilities in preparation
for significant business expansion expected over the coming 12-18
months.
Second Quarter 2018 Results
Revenues for the second quarter of 2018 were $319.3 million, a decrease
of 5.1% compared to $336.5 million in the second quarter of 2017.
Excluding the impact on revenues for the second quarter of 2018 of
changes in commodity-related pricing, foreign exchange rates and sales
of flexible resealable pouch and nutrition bar products, revenues in the
second quarter of 2018 decreased by 0.6% compared with the second
quarter of 2017.
The Global Ingredients segment generated revenues from external
customers of $146.7 million, an increase of 0.4% compared to $146.1
million in the second quarter of 2017. Excluding the impact on revenues
of changes in commodity-related pricing and foreign exchange rates,
Global Ingredients revenue in the second quarter decreased 0.6%. Strong
demand continued for internationally sourced organic ingredients, which
grew 6.8% during the quarter, excluding the effect of commodity prices
and foreign exchange. This growth was largely offset by a 14.2% decline
in domestically sourced ingredients, reflecting the previously announced
exit from certain domestically-sourced grain varieties in 2017, as well
as revenue declines in the sunflower operations as a result of soft
market conditions.
The Consumer Products segment generated revenues of $172.6 million
during the second quarter of 2018, a decrease of 9.3% compared to $190.3
million in the second quarter of 2017. Excluding the impact of
commodity-related pricing and sales of resealable pouch and nutrition
bar products, which have been exited, Consumer Products revenue in the
second quarter decreased by 0.6%. The decline primarily reflects a 3.3%
decline in sales of frozen fruit and fruit ingredients, partially offset
by 1.6% growth in the Healthy Beverage platform, consisting of higher
sales of aseptic non-dairy and broth products, partially offset by lower
sales of premium juice during the quarter, and strong sales of fruit
snacks that led to 7.6% growth in the Healthy Snacks platform, excluding
sales of resealable pouch and nutrition bar products.
Gross profit decreased $7.3 million, or 17.6%, to $34.3 million for the
quarter ended June 30, 2018, compared with $41.7 million for the quarter
ended July 1, 2017. Global Ingredients accounted for $6.8 million of the
decrease in gross profit which was largely due to the impact that
foreign exchange and commodity price movements had on certain contracts
within the European-based operations of the international organic
ingredients platform. During the second quarter of 2018, the Company
recognized a non-cash $4.3 million foreign exchange loss on U.S.
dollar-denominated raw material purchase contracts, compared with a
non-cash foreign exchange gain of $3.7 million in the second quarter of
2017, which reflected a significant strengthening of the U.S. dollar
versus the euro in the second quarter of 2018, compared with a
significant weakening of the U.S. dollar versus the euro in the second
quarter of 2017. Partially offsetting this, gross profit for the second
quarter of 2018 included a gain of $1.8 million on commodity futures
contracts used to hedge our organic cocoa position, compared with a gain
of $0.2 million in the second quarter of 2017. To limit economic
exposure to fluctuations in the price of cocoa the Company sells futures
contracts to offset its physical ownership of organic cocoa. The
increased gain in the second quarter of 2018 compared to the prior year
reflects a steeper decline in the price of cocoa, coupled with an
increased ownership position due to the expansion of cocoa processing
operations. Consumer Products accounted for $0.5 million of the decrease
in gross profit reflecting lower sales volume and pricing, together with
higher costs of manufacturing in frozen fruit. These factors were mostly
offset by increased volumes and plant efficiencies in our beverage and
snack operations, as well as operational savings from the discontinuance
of flexible resealable pouch and nutrition bar production.
As a percentage of revenues, gross profit for the quarter ended June 30,
2018 was 10.8% compared to 12.4% for the quarter ended July 1, 2017, a
decrease of 1.6%. The gross profit percentage for the second quarter of
2018 would have been approximately 10.6%, excluding the recovery of $1.2
million of previously-incurred product withdrawal costs from a
third-party supplier, partially offset by start-up costs of $0.7 million
related to new roasting equipment for domestically-sourced grains and
seeds. The gross profit percentage for the second quarter of 2017 would
have been approximately 12.5%, excluding the impact of facility closure
costs under the Value Creation Plan of $0.3 million. On an adjusted
basis, the gross profit percentage reflected the net negative impact of
the foreign exchange and commodity hedging results described above,
partially offset by a 90 basis point improvement in gross profit
percentage in the Consumer Products segment driven by continued growth
in aseptic beverages and snacks and the exit from pouches and nutrition
bars.
Operating income¹ was $4.6 million, or 1.5% of revenues, compared to
$2.6 million, or 0.8% of revenues in the second quarter of 2017. The
increase in operating income year-over-year primarily reflects lower
non-structural SG&A costs when compared to the prior year, which offset
the decline in gross profit, as well as a $1.2 million decrease in
foreign exchange losses, which included an approximately $3.0 million
decrease in losses related to forward currency contracts within the
international organic ingredient operations, which partially offset the
foreign exchange movement within gross profit. Operating income would
have been $4.5 million, or 1.4% of revenues excluding the $1.2 million
recovery of product withdrawal costs, offset by $0.3 million of
non-structural costs in SG&A related to the Value Creation Plan, and
$0.7 million of costs related to equipment start-up, as compared to a
normalized operating income of $9.9 million or 2.9% of revenues in the
second quarter of 2017.
Adjusted EBITDA¹ was $14.8 million or 4.6% of revenues in the second
quarter of 2018, compared to $19.4 million or 5.8% of revenues in the
second quarter of 2017. Excluding flexible resealable pouch and
nutrition bar operations, adjusted EBITDA for the quarter ended June 30,
2018 was $14.4 million, compared with $21.5 million for the quarter
ended July 1, 2017.
The Company reported a loss attributable to common shareholders of $5.1
million, or $0.06 per common share, compared to a loss attributable to
common shareholders of $2.4 million, or $0.03 per common share during
the second quarter of 2017. Adjusted loss¹ in the second quarter of 2018
was $5.0 million or a loss of $0.06 per common share, compared to $0.7
million or $0.01 per common share in the second quarter of 2017. Please
refer to the discussion and table below under “Non-GAAP Measures -
Adjusted Earnings”.
Balance Sheet and Cash Flow
At June 30, 2018, SunOpta’s balance sheet reflected total assets of
$1,018.8 million and total debt of $509.1 million. During the second
quarter of 2018, cash used in operating activities was $34.2 million,
compared to $25.8 million during the second quarter of 2017. The
increase in cash used in operations reflects increased investment into
working capital, mainly inventory, to support growth in the organic
ingredient operations and timing of the fruit harvest compared to 2017.
Partially offsetting the increased cash used to fund working capital,
cash provided by operating activities improved compared to the second
quarter of 2017 due to lower non-structural cash costs incurred in
support of the Value Creation Plan. Cash used in investing activities
during the second quarter of 2018 was $10.0 million, compared to $6.8
million in the prior year period due mainly to increased capital
expenditures.
Conference Call
SunOpta plans to host a conference call at 9:00 A.M. Eastern time on
Wednesday, August 8, 2018, to discuss the second quarter financial
results. After opening remarks, there will be a question and answer
period. This conference call can be accessed via a link on SunOpta’s
website at www.sunopta.com
under the “Investors” section. To listen to the live call over the
Internet, please go to SunOpta’s website at least 15 minutes early to
register, download and install any necessary audio software.
Additionally, the call may be accessed with the toll-free dial-in number
1 (877) 312-9198 or International dial-in number 1 (631) 291-4622. If
you are unable to listen live, the conference call will be archived and
can be accessed for approximately 90 days on the Company’s website.
¹ See discussion of non-GAAP measures
About SunOpta Inc.
SunOpta Inc. is a leading global company focused on organic,
non-genetically modified ("non-GMO") and specialty foods. SunOpta
specializes in the sourcing, processing and packaging of organic and
non-GMO food products, integrated from seed through packaged products;
with a focus on strategic vertically integrated business models.
SunOpta's organic and non-GMO food operations revolve around value-added
grain, seed, fruit and vegetable-based product offerings, supported by a
global sourcing and supply infrastructure.
Forward-Looking Statements
Certain statements included in this press release may be considered
"forward-looking statements" within the meaning of the United States
Private Securities Litigation Reform Act of 1995 and applicable Canadian
securities legislation, which are based on information available to us
on the date of this release. These forward-looking statements include,
but are not limited to, the anticipated benefits of our efforts to
transform our business operations, including our Value Creation Plan and
our anticipated revenue growth during the second half of 2018; the
estimated amount and timing of EBITDA enhancements attributable to
improvements initiated or implemented to date pursuant to our Value
Creation Plan; the estimated cost and increased capacity as a result of
the expansion of our Allentown beverage facility; the estimated
timeframes for reaching the designed run-rate for our cocoa facility in
the Netherlands, commissioning of our Crookston facility, achieving
overall capacity utilization of 85% for our aseptic manufacturing
facilities, and shipping incremental frozen fruit offerings; expected
productivity and cost improvements as a result of our food safety and
quality and our SunOpta 360 continuous improvement initiatives; and
sustainable business improvements resulting from our enhanced employee
health and safety, advanced aseptic capacity planning model
capabilities, and other process sustainability initiatives.. Generally,
forward-looking statements do not relate strictly to historical or
current facts and are typically accompanied by words such as
“continued”, “anticipate”, “believes”, “expect”, “will”, “targeting”,
"should", "would", "plans", "becoming", "estimated", "intend",
"confident", "can", "may", "project", "potential", "intention", "might",
"predict" or other similar terms and phrases intended to identify these
forward-looking statements. Forward-looking statements are based on
information available to us on the date of this release and are based on
estimates and assumptions made by the Company in light of its experience
and its perception of historical trends, current conditions and expected
future developments including, but not limited to, our planned expansion
initiatives, portfolio optimization and productivity efforts, our
expectations regarding commodity pricing, margins and hedging results,
improved availability and field prices for fruit, procurement and
logistics savings, freight lane cost reductions, yield and throughput
enhancements, and labor cost reductions, as well as other factors the
Company believes are appropriate in the circumstances including, but not
limited to, general economic conditions, continued consumer interest in
health and wellness, ability to maintain product pricing levels, current
customer demand, planned facility and operational expansions, closures
and divestitures, competitive intensity, cost rationalization, product
development initiatives, and alternative potential uses for our capital
resources. Whether actual timing and results will agree with
expectations and predications of the Company is subject to many risks
and uncertainties including, but not limited to, issues or delays in the
successful integration of the operations, systems and personnel of
recently acquired businesses with those of the Company, incurring or
experiencing unanticipated costs and/or delays or difficulties, future
levels of revenues being lower than expected, costs being higher than
expected, inability to realize synergies to the extent anticipated and
conditions affecting the frozen fruit industry generally; failure or
inability to implement portfolio changes, process improvements,
go-to-market improvements and process sustainability strategies in a
timely manner; delays or difficulties in exiting certain businesses and
product lines including the failure of purchasers to satisfy the
purchase price and inability to satisfy the conditions of closing for
any such transactions; changes in the level of capital investment; local
and global political and economic conditions; consumer spending patterns
and changes in market trends; decreases in customer demand; delayed or
unsuccessful product development efforts; potential product recalls;
working capital management; availability and pricing of raw materials
and supplies; potential covenant breaches under our credit facilities;
and other risks described from time to time under "Risk Factors" in the
Company's Annual Report on Form 10-K and its Quarterly Reports on Form
10-Q (available at www.sec.gov).
Consequently, all forward-looking statements made herein are qualified
by these cautionary statements and there can be no assurance that the
actual results or developments anticipated by the Company will be
realized. The Company undertakes no obligation to publicly correct or
update the forward-looking statements in this document, in other
documents, or on its website to reflect future events or circumstances,
except as may be required under applicable securities laws.
|
|
|
|
|
|
|
|
|
SunOpta Inc. |
Consolidated Statements of Operations
|
For the quarters and two quarters ended June 30, 2018 and July 1,
2017
|
(Unaudited)
|
(All dollar amounts expressed in thousands of U.S. dollars, except
per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter ended
|
|
Two quarters ended
|
|
|
|
|
|
June 30, 2018
|
|
July 1, 2017
|
|
June 30, 2018
|
|
July 1, 2017
|
|
|
|
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
319,308
|
|
|
336,454
|
|
|
631,960
|
|
|
666,485
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of goods sold |
|
284,962
|
|
|
294,792
|
|
|
563,930
|
|
|
586,124
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
34,346
|
|
|
41,662
|
|
|
68,030
|
|
|
80,361
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses
|
|
26,948
|
|
|
35,039
|
|
|
55,236
|
|
|
73,311
|
|
Intangible asset amortization
|
|
2,768
|
|
|
2,809
|
|
|
5,539
|
|
|
5,612
|
|
Other expense, net
|
|
583
|
|
|
607
|
|
|
181
|
|
|
6,050
|
|
Foreign exchange loss (gain)
|
|
(11
|
)
|
|
1,195
|
|
|
951
|
|
|
1,775
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) before the following |
|
4,058
|
|
|
2,012
|
|
|
6,123
|
|
|
(6,387
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net
|
|
8,474
|
|
|
7,695
|
|
|
16,694
|
|
|
15,449
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income taxes |
|
(4,416
|
)
|
|
(5,683
|
)
|
|
(10,571
|
)
|
|
(21,836
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Recovery of income taxes
|
|
(1,290
|
)
|
|
(5,581
|
)
|
|
(2,983
|
)
|
|
(10,550
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
(3,126
|
)
|
|
(102
|
)
|
|
(7,588
|
)
|
|
(11,286
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) attributable to non-controlling interests
|
|
48
|
|
|
306
|
|
|
(51
|
)
|
|
520
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss attributable to SunOpta Inc. |
|
(3,174
|
)
|
|
(408
|
)
|
|
(7,537
|
)
|
|
(11,806
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends and accretion on Series A Preferred Stock
|
|
(1,974
|
)
|
|
(1,954
|
)
|
|
(3,941
|
)
|
|
(3,894
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss attributable to common shareholders |
|
(5,148
|
)
|
|
(2,362
|
)
|
|
(11,478
|
)
|
|
(15,700
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss per share |
|
|
|
|
|
|
|
|
|
Basic
|
|
(0.06
|
)
|
|
(0.03
|
)
|
|
(0.13
|
)
|
|
(0.18
|
)
|
|
Diluted
|
|
(0.06
|
)
|
|
(0.03
|
)
|
|
(0.13
|
)
|
|
(0.18
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding (000s) |
|
|
|
|
|
|
|
|
|
Basic
|
|
86,968
|
|
|
86,213
|
|
|
86,889
|
|
|
86,062
|
|
|
Diluted
|
|
86,968
|
|
|
86,213
|
|
|
86,889
|
|
|
86,062
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SunOpta Inc. |
Consolidated Balance Sheets
|
As at June 30, 2018 and December 30, 2017
|
(Unaudited)
|
(All dollar amounts expressed in thousands of U.S. dollars)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2018
|
|
December 30, 2017
|
|
|
|
|
|
$
|
|
$
|
|
|
|
|
|
|
|
|
ASSETS |
|
|
|
|
Current assets |
|
|
|
|
|
Cash and cash equivalents
|
|
2,087
|
|
|
3,228
|
|
|
Accounts receivable
|
|
137,047
|
|
|
125,152
|
|
|
Inventories
|
|
382,931
|
|
|
354,978
|
|
|
Prepaid expenses and other current assets
|
|
35,958
|
|
|
33,213
|
|
|
Income taxes recoverable
|
|
10,264
|
|
|
12,006
|
|
Total current assets |
|
568,287
|
|
|
528,577
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment |
|
167,208
|
|
|
163,624
|
|
Goodwill |
|
109,320
|
|
|
109,533
|
|
Intangible assets |
|
166,489
|
|
|
172,059
|
|
Deferred income taxes |
|
364
|
|
|
363
|
|
Other assets |
|
7,163
|
|
|
8,017
|
|
|
|
|
|
|
|
|
|
Total assets |
|
1,018,831
|
|
|
982,173
|
|
|
|
|
|
|
|
|
|
LIABILITIES |
|
|
|
|
Current liabilities |
|
|
|
|
|
Bank indebtedness
|
|
281,523
|
|
|
234,090
|
|
|
Accounts payable and accrued liabilities
|
|
166,715
|
|
|
161,364
|
|
|
Customer and other deposits
|
|
4,203
|
|
|
4,901
|
|
|
Income taxes payable
|
|
1,906
|
|
|
1,351
|
|
|
Other current liabilities
|
|
1,499
|
|
|
818
|
|
|
Current portion of long-term debt
|
|
2,086
|
|
|
2,228
|
|
|
Current portion of long-term liabilities
|
|
4,505
|
|
|
5,300
|
|
Total current liabilities |
|
462,437
|
|
|
410,052
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
225,476
|
|
|
225,805
|
|
Long-term liabilities |
|
2,360
|
|
|
8,352
|
|
Deferred income taxes |
|
13,580
|
|
|
15,850
|
|
Total liabilities |
|
703,853
|
|
|
660,059
|
|
|
|
|
|
|
|
|
|
Series A Preferred Stock |
|
80,734
|
|
|
80,193
|
|
|
|
|
|
|
|
|
|
EQUITY |
|
|
|
|
SunOpta Inc. shareholders’ equity |
|
|
|
|
|
Common shares
|
|
312,520
|
|
|
308,899
|
|
|
Additional paid-in capital
|
|
28,900
|
|
|
28,006
|
|
|
Accumulated deficit
|
|
(100,515
|
)
|
|
(89,291
|
)
|
|
Accumulated other comprehensive loss
|
|
(8,323
|
)
|
|
(7,268
|
)
|
|
|
|
|
|
232,582
|
|
|
240,346
|
|
Non-controlling interests |
|
1,662
|
|
|
1,575
|
|
Total equity |
|
234,244
|
|
|
241,921
|
|
|
|
|
|
|
|
|
|
Total equity and liabilities |
|
1,018,831
|
|
|
982,173
|
|
|
|
|
|
|
|
|
|
SunOpta Inc. |
Consolidated Statements of Cash Flows
|
For the quarters and two quarters ended June 30, 2018 and July 1,
2017
|
(Unaudited)
|
(Expressed in thousands of U.S. dollars)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter ended
|
|
Two quarters ended
|
|
|
|
|
|
June 30, 2018
|
|
July 1, 2017
|
|
June 30, 2018
|
|
July 1, 2017
|
|
|
|
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH PROVIDED BY (USED IN) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating activities |
|
|
|
|
|
|
|
|
Net loss
|
|
(3,126
|
)
|
|
(102
|
)
|
|
(7,588
|
)
|
|
(11,286
|
)
|
Items not affecting cash:
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
8,189
|
|
|
8,167
|
|
|
16,330
|
|
|
16,347
|
|
|
Amortization of debt issuance costs
|
|
600
|
|
|
652
|
|
|
1,208
|
|
|
1,138
|
|
|
Deferred income taxes
|
|
(865
|
)
|
|
(3,823
|
)
|
|
(2,151
|
)
|
|
(9,915
|
)
|
|
Stock-based compensation
|
|
2,104
|
|
|
1,286
|
|
|
4,275
|
|
|
2,138
|
|
|
Unrealized gain on derivative contracts
|
|
(2,764
|
)
|
|
(1,267
|
)
|
|
(1,243
|
)
|
|
(1,229
|
)
|
|
Fair value of contingent consideration
|
|
43
|
|
|
204
|
|
|
(2,373
|
)
|
|
204
|
|
|
Impairment of long-lived assets
|
|
70
|
|
|
-
|
|
|
409
|
|
|
3,723
|
|
|
Other
|
|
(148
|
)
|
|
(244
|
)
|
|
(147
|
)
|
|
(101
|
)
|
|
Changes in non-cash working capital
|
|
(38,324
|
)
|
|
(30,648
|
)
|
|
(35,435
|
)
|
|
(7,313
|
)
|
Net cash flows from operations
|
|
(34,221
|
)
|
|
(25,775
|
)
|
|
(26,715
|
)
|
|
(6,294
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Investing activities |
|
|
|
|
|
|
|
|
Purchases of property, plant and equipment
|
|
(10,428
|
)
|
|
(7,143
|
)
|
|
(17,163
|
)
|
|
(16,167
|
)
|
Proceeds from sale of assets
|
|
30
|
|
|
51
|
|
|
730
|
|
|
301
|
|
Other
|
|
389
|
|
|
254
|
|
|
389
|
|
|
364
|
|
Net cash flows from investing activities
|
|
(10,009
|
)
|
|
(6,838
|
)
|
|
(16,044
|
)
|
|
(15,502
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Financing activities |
|
|
|
|
|
|
|
|
Increase under line of credit facilities
|
|
49,885
|
|
|
36,690
|
|
|
50,194
|
|
|
29,349
|
|
Repayment of long-term debt
|
|
(415
|
)
|
|
(589
|
)
|
|
(937
|
)
|
|
(1,116
|
)
|
Payment of cash dividends on Series A Preferred Stock
|
|
(1,700
|
)
|
|
(1,700
|
)
|
|
(3,400
|
)
|
|
(3,291
|
)
|
Proceeds from the exercise of stock options and employee share
purchases, net of withholding taxes paid
|
|
91
|
|
|
2,535
|
|
|
240
|
|
|
3,629
|
|
Payment of contingent consideration
|
|
(4,399
|
)
|
|
(4,330
|
)
|
|
(4,399
|
)
|
|
(4,330
|
)
|
Other
|
|
(5
|
)
|
|
(101
|
)
|
|
(45
|
)
|
|
(303
|
)
|
Net cash flows from financing activities
|
|
43,457
|
|
|
32,505
|
|
|
41,653
|
|
|
23,938
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign exchange gain (loss) on cash held in a foreign currency
|
|
(64
|
)
|
|
54
|
|
|
(35
|
)
|
|
64
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease) in cash and cash equivalents in the period
|
|
(837
|
)
|
|
(54
|
)
|
|
(1,141
|
)
|
|
2,206
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents - beginning of the period
|
|
2,924
|
|
|
3,511
|
|
|
3,228
|
|
|
1,251
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents - end of the period
|
|
2,087
|
|
|
3,457
|
|
|
2,087
|
|
|
3,457
|
|
|
|
|
|
|
|
|
|
|
|
SunOpta Inc.
|
Segmented Information
|
For the quarters and two quarters ended June 30, 2018 and July 1,
2017
|
Unaudited
|
(Expressed in thousands of U.S. dollars)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter ended
|
|
Two quarters ended
|
|
|
|
|
|
June 30, 2018
|
|
July 1, 2017
|
|
June 30, 2018
|
|
July 1, 2017
|
|
|
|
|
|
$
|
|
$
|
|
$
|
|
$
|
Segment revenues from external customers: |
|
|
|
|
|
|
|
|
|
Global Ingredients
|
|
146,685
|
|
|
146,126
|
|
|
283,016
|
|
|
272,768
|
|
|
Consumer Products
|
|
172,623
|
|
|
190,328
|
|
|
348,944
|
|
|
393,717
|
|
|
|
Total segment revenues from external customers
|
|
319,308
|
|
|
336,454
|
|
|
631,960
|
|
|
666,485
|
|
|
|
|
|
|
|
|
|
|
|
Segment gross profit: |
|
|
|
|
|
|
|
|
|
Global Ingredients
|
|
13,464
|
|
|
20,284
|
|
|
28,099
|
|
|
35,380
|
|
|
Consumer Products
|
|
20,882
|
|
|
21,378
|
|
|
39,931
|
|
|
44,981
|
|
|
|
Total segment gross profit
|
|
34,346
|
|
|
41,662
|
|
|
68,030
|
|
|
80,361
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment operating income (loss): |
|
|
|
|
|
|
|
|
|
Global Ingredients
|
|
2,965
|
|
|
7,913
|
|
|
6,067
|
|
|
12,114
|
|
|
Consumer Products
|
|
4,762
|
|
|
4,679
|
|
|
8,078
|
|
|
11,177
|
|
|
Corporate Services
|
|
(3,086
|
)
|
|
(9,973
|
)
|
|
(7,841
|
)
|
|
(23,628
|
)
|
|
|
Total segment operating income
|
|
4,641
|
|
|
2,619
|
|
|
6,304
|
|
|
(337
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment gross profit percentage: |
|
|
|
|
|
|
|
|
|
Global Ingredients
|
|
9.2
|
%
|
|
13.9
|
%
|
|
9.9
|
%
|
|
13.0
|
%
|
|
Consumer Products
|
|
12.1
|
%
|
|
11.2
|
%
|
|
11.4
|
%
|
|
11.4
|
%
|
|
|
Total segment gross profit percentage
|
|
10.8
|
%
|
|
12.4
|
%
|
|
10.8
|
%
|
|
12.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment operating income percentage: |
|
|
|
|
|
|
|
|
|
Global Ingredients
|
|
2.0
|
%
|
|
5.4
|
%
|
|
2.1
|
%
|
|
4.4
|
%
|
|
Consumer Products
|
|
2.8
|
%
|
|
2.5
|
%
|
|
2.3
|
%
|
|
2.8
|
%
|
|
|
Total segment operating income
|
|
1.5
|
%
|
|
0.8
|
%
|
|
1.0
|
%
|
|
-0.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Measures
In addition to reporting financial results in accordance with U.S. GAAP,
the Company provides additional information about its operating results
regarding segment operating income, adjusted earnings and adjusted
earnings before interest, taxes, depreciation and amortization
(“Adjusted EBITDA”), which are not measures in accordance with U.S.
GAAP. We believe that segment operating income, adjusted earnings and
adjusted EBITDA assist investors in comparing performance across
reporting periods on a consistent basis by excluding items that are not
indicative of the Company’s operating performance. The non-GAAP measures
of segment operating income, adjusted earnings and adjusted EBITDA
should not be considered in isolation or as a substitute for performance
measures calculated in accordance with U.S. GAAP.
In order to evaluate the Company’s results of operations, we use certain
other non-GAAP measures that we believe enhance an investor’s ability to
derive meaningful period-over-period comparisons and trends from the
results of operations. In particular, we evaluate the Company’s revenues
on a basis that excludes the effects of fluctuations in commodity
pricing and foreign exchange rates. In addition, we exclude specific
items from the Company’s reported results that due to their nature or
size, we do not expect to occur as part of our normal business on a
regular basis. These items are identified in the tables below. These
non-GAAP measures are presented solely to allow investors to more fully
assess the Company’s results of operations and should not considered in
isolation of, or as substitutes for an analysis of the Company’s results
as reported under U.S. GAAP.
Adjusted Earnings/Loss
When assessing our financial performance, we use an internal measure
that excludes charges and gains that we believe are not reflective of
normal operations. This information is provided to allow investors to
make meaningful comparisons of the Company’s operating performance
between periods and to view the Company’s business from the same
perspective as Company management. Adjusted earnings/loss and adjusted
earnings/loss per diluted share should not be considered in isolation or
as a substitute for performance measures calculated in accordance with
U.S. GAAP.
The following is a tabular presentation of adjusted earnings/loss and
adjusted earnings/loss per diluted share, including a reconciliation
from loss attributable to common shareholders, which the Company
believes to be the most directly comparable U.S. GAAP financial measure.
In addition, due to the exit from flexible resealable pouch and
nutrition bar product lines and operations, we have prepared these
tables in a columnar format to present the effect of these operations on
our consolidated results for the current and comparative periods. We
believe this presentation assists investors in assessing the results of
the operations we have exited and the effect of those operations on our
financial performance.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Excluding flexible resealable pouch and nutrition bar
|
|
Flexible resealable pouch and nutrition bar
|
|
Consolidated
|
|
|
|
|
|
|
|
|
Per Diluted Share
|
|
|
|
Per Diluted Share
|
|
|
|
Per Diluted Share
|
|
For the quarter ended |
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
June 30, 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings (loss)
|
|
(3,413
|
)
|
|
|
|
287
|
|
|
|
|
(3,126
|
)
|
|
|
|
Less: earnings attributable to non-controlling interests
|
|
(48
|
)
|
|
|
|
-
|
|
|
|
|
(48
|
)
|
|
|
|
Less: dividends and accretion of Series A Preferred Stock
|
|
(1,974
|
)
|
|
|
|
-
|
|
|
|
|
(1,974
|
)
|
|
|
|
Earnings (loss) attributable to common shareholders
|
|
(5,435
|
)
|
|
(0.06
|
)
|
|
287
|
|
|
-
|
|
|
(5,148
|
)
|
|
(0.06
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted for:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equipment start-up costs(a) |
|
730
|
|
|
|
|
-
|
|
|
|
|
730
|
|
|
|
|
|
Costs related to the Value Creation Plan(b) |
|
669
|
|
|
|
|
(30
|
)
|
|
|
|
639
|
|
|
|
|
|
Product withdrawal and recall costs(c) |
|
122
|
|
|
|
|
-
|
|
|
|
|
122
|
|
|
|
|
|
Other(d) |
|
122
|
|
|
|
|
-
|
|
|
|
|
122
|
|
|
|
|
|
Recovery of product withdrawal costs(e) |
|
(1,200
|
)
|
|
|
|
-
|
|
|
|
|
(1,200
|
)
|
|
|
|
|
Net income tax effect(f) |
|
(258
|
)
|
|
|
|
8
|
|
|
|
|
(250
|
)
|
|
|
|
Adjusted earnings (loss)
|
|
(5,250
|
)
|
|
(0.06
|
)
|
|
265
|
|
|
-
|
|
|
(4,985
|
)
|
|
(0.06
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
July 1, 2017 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings (loss)
|
|
1,305
|
|
|
|
|
(1,407
|
)
|
|
|
|
(102
|
)
|
|
|
|
Add: earnings attributable to non-controlling interests
|
|
(306
|
)
|
|
|
|
-
|
|
|
|
|
(306
|
)
|
|
|
|
Less: dividends and accretion of Series A Preferred Stock
|
|
(1,954
|
)
|
|
|
|
-
|
|
|
|
|
(1,954
|
)
|
|
|
|
Loss attributable to common shareholders
|
|
(955
|
)
|
|
(0.01
|
)
|
|
(1,407
|
)
|
|
(0.02
|
)
|
|
(2,362
|
)
|
|
(0.03
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted for:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs related to the Value Creation Plan(g) |
|
7,688
|
|
|
|
|
-
|
|
|
|
|
7,688
|
|
|
|
|
|
Other(d) |
|
182
|
|
|
|
|
-
|
|
|
|
|
182
|
|
|
|
|
|
Net income tax effect(f) |
|
(6,254
|
)
|
|
|
|
-
|
|
|
|
|
(6,254
|
)
|
|
|
|
Adjusted earnings (loss)
|
|
661
|
|
|
0.01
|
|
|
(1,407
|
)
|
|
(0.02
|
)
|
|
(746
|
)
|
|
(0.01
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
|
|
|
Reflects costs related to the start-up of new roasting equipment,
which were recorded in cost of goods sold.
|
(b)
|
|
|
|
Reflects professional fees of $0.3 million recorded in SG&A
expenses; and asset impairment, facility closure and employee
termination costs of $0.3 million recorded in other expense, all
related to the Value Creation Plan.
|
(c)
|
|
|
|
Reflects product withdrawal and recall costs not eligible for
reimbursement under our insurance policies, which were recorded in
other expense.
|
(d)
|
|
|
|
Other included the accretion of contingent consideration obligations
and gain/loss on the sale of assets, which were recorded in other
expense/income.
|
(e)
|
|
|
|
Reflects the recovery from a third-party supplier of $1.2 million of
costs we incurred relating to the withdrawal of certain
consumer-packaged products due to quality-related issues, which was
recorded in cost of goods sold. Costs incurred related to this
withdrawal were recognized in cost of goods sold in the fourth
quarter of 2016.
|
(f)
|
|
|
|
Reflects the tax effect of the preceding adjustments to earnings and
reflects an overall estimated annual effective tax rate of
approximately 26% for the two quarters ended June 30, 2018 (July 1,
2017 – 30%) on adjusted earnings before tax.
|
(g)
|
|
|
|
Reflects facility closure costs of $0.3 million recorded in cost of
goods sold; consulting fees, temporary labor, employee recruitment,
relocation and retention costs of $7.0 million recorded in SG&A
expenses; and employee termination costs of $0.4 million recorded in
other expense, all related to the Value Creation Plan.
|
|
|
|
|
|
|
|
|
|
|
|
|
Excluding flexible resealable pouch and nutrition bar
|
|
Flexible resealable pouch and nutrition bar
|
|
Consolidated
|
|
|
|
|
|
|
|
|
Per Diluted Share
|
|
|
|
Per Diluted Share
|
|
|
|
Per Diluted Share
|
|
For the two quarters ended |
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
June 30, 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
(6,891
|
)
|
|
|
|
(697
|
)
|
|
|
|
(7,588
|
)
|
|
|
|
Less: loss attributable to non-controlling interests
|
|
51
|
|
|
|
|
-
|
|
|
|
|
51
|
|
|
|
|
Less: dividends and accretion of Series A Preferred Stock
|
|
(3,941
|
)
|
|
|
|
-
|
|
|
|
|
(3,941
|
)
|
|
|
|
Loss attributable to common shareholders
|
|
(10,781
|
)
|
|
(0.12
|
)
|
|
(697
|
)
|
|
(0.01
|
)
|
|
(11,478
|
)
|
|
(0.13
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted for:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs related to the Value Creation Plan(a) |
|
1,653
|
|
|
|
|
1,181
|
|
|
|
|
2,834
|
|
|
|
|
|
Equipment start-up costs(b) |
|
730
|
|
|
|
|
-
|
|
|
|
|
730
|
|
|
|
|
|
Product withdrawal and recall costs(c) |
|
445
|
|
|
|
|
-
|
|
|
|
|
445
|
|
|
|
|
|
Other(d) |
|
115
|
|
|
|
|
-
|
|
|
|
|
115
|
|
|
|
|
|
Fair value adjustment on contingent consideration(e) |
|
(2,500
|
)
|
|
|
|
-
|
|
|
|
|
(2,500
|
)
|
|
|
|
|
Recovery of product withdrawal costs(f) |
|
(1,200
|
)
|
|
|
|
-
|
|
|
|
|
(1,200
|
)
|
|
|
|
|
Net income tax effect(g) |
|
(37
|
)
|
|
|
|
(307
|
)
|
|
|
|
(344
|
)
|
|
|
|
Adjusted earnings (loss)
|
|
(11,575
|
)
|
|
(0.13
|
)
|
|
177
|
|
|
-
|
|
|
(11,398
|
)
|
|
(0.13
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
July 1, 2017 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
(8,665
|
)
|
|
|
|
(2,621
|
)
|
|
|
|
(11,286
|
)
|
|
|
|
Add: earnings attributable to non-controlling interests
|
|
(520
|
)
|
|
|
|
-
|
|
|
|
|
(520
|
)
|
|
|
|
Less: dividends and accretion of Series A Preferred Stock
|
|
(3,894
|
)
|
|
|
|
-
|
|
|
|
|
(3,894
|
)
|
|
|
|
Loss attributable to common shareholders
|
|
(13,079
|
)
|
|
(0.15
|
)
|
|
(2,621
|
)
|
|
(0.03
|
)
|
|
(15,700
|
)
|
|
(0.18
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted for:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs related to the Value Creation Plan(h) |
|
24,971
|
|
|
|
|
-
|
|
|
|
|
24,971
|
|
|
|
|
|
Product withdrawal and recall costs(i) |
|
1,008
|
|
|
|
|
-
|
|
|
|
|
1,008
|
|
|
|
|
|
Other(d) |
|
(127
|
)
|
|
|
|
-
|
|
|
|
|
(127
|
)
|
|
|
|
|
Net income tax effect(g) |
|
(11,786
|
)
|
|
|
|
-
|
|
|
|
|
(11,786
|
)
|
|
|
|
Adjusted earnings (loss)
|
|
987
|
|
|
0.01
|
|
|
(2,621
|
)
|
|
(0.03
|
)
|
|
(1,634
|
)
|
|
(0.02
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
|
|
|
Reflects the write-down of remaining flexible resealable pouch and
nutrition bar inventories of $0.1 million recorded in cost of goods
sold; professional and consulting fees, and employee recruitment and
relocation costs of $0.6 million recorded in SG&A expenses; and
asset impairment, facility closure and employee termination costs of
$2.1 million recorded in other expense, all related to the Value
Creation Plan.
|
(b)
|
|
|
|
Reflects costs related to the start-up of new roasting equipment,
which were recorded in cost of goods sold.
|
(c)
|
|
|
|
Reflects product withdrawal and recall costs not eligible for
reimbursement under our insurance policies, which were recorded in
other expense.
|
(d)
|
|
|
|
Other included the accretion of contingent consideration obligations
and gain/loss on the sale of assets, which were recorded in other
expense/income.
|
(e)
|
|
|
|
Reflects a fair value adjustment of $2.5 million to reduce the
expected contingent consideration that may be payable in 2019 under
an earn-out arrangement with the former unitholders of Citrusource
LLC (which we acquired in March 2015), based on the projected
results for the business in fiscal 2018, which was recorded in other
income.
|
(f)
|
|
|
|
Reflects the recovery from a third-party supplier of $1.2 million of
costs we incurred relating to the withdrawal of certain
consumer-packaged products due to quality-related issues, which was
recorded in cost of goods sold. Costs incurred related to this
withdrawal were recognized in cost of goods sold in the fourth
quarter of 2016.
|
(g)
|
|
|
|
Reflects the tax effect of the preceding adjustments to earnings and
reflects an overall estimated annual effective tax rate of
approximately 26% for the two quarters ended June 30, 2018 (July 1,
2017 – 30%) on adjusted earnings before tax.
|
(h)
|
|
|
|
Reflects facility closure costs of $0.6 million recorded in cost of
goods sold; consulting fees, temporary labor, employee recruitment,
relocation and retention costs of $18.4 million recorded in SG&A
expenses; and asset impairment and employee termination costs of
$5.9 million recorded in other expense, all related to the Value
Creation Plan.
|
(i)
|
|
|
|
Reflects costs related to the recall of certain sunflower kernel
products initiated in the second quarter of 2016, including a $0.7
million adjustment for the estimated lost gross profit caused by the
sunflower recall, which reflected a shortfall in revenues in the
first quarter of 2017 against first quarter 2016 volumes of
approximately $3.3 million, less associated cost of goods sold of
approximately $2.6 million; and $0.3 million of direct costs
recorded in other expense that are not eligible for reimbursement
under our insurance policies.
|
|
|
|
|
|
Segment Operating Income/Loss and Adjusted EBITDA
The Company defines segment operating income/loss as net earnings/loss
before income taxes, interest expense and other income/expense items,
and adjusted EBITDA as segment operating income/loss plus depreciation,
amortization, non-cash stock-based compensation, and other unusual items
that affect the comparability of operating performance as identified
above in the determination of adjusted earnings. The following is a
tabular presentation of segment operating income/loss and adjusted
EBITDA, including a reconciliation to net loss, which the Company
believes to be the most directly comparable U.S. GAAP financial measure.
In addition, as with “adjusted earnings/loss” presented above, we have
prepared these tables in a columnar format to present the effect of
flexible resealable pouch and nutrition bar operations on our
consolidated results for the current and comparative periods. We believe
this presentation assists investors in assessing the results of the
operations we have exited and the effect of those operations on our
financial performance.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Excluding flexible resealable pouch and nutrition bar
|
|
Flexible resealable pouch and nutrition bar
|
|
Consolidated
|
|
For the quarter ended |
|
$
|
|
$
|
|
$
|
|
June 30, 2018 |
|
|
|
|
|
|
|
Net earnings (loss)
|
|
(3,413
|
)
|
|
287
|
|
|
(3,126
|
)
|
|
Recovery of income taxes
|
|
(1,391
|
)
|
|
101
|
|
|
(1,290
|
)
|
|
Interest expense, net
|
|
8,474
|
|
|
-
|
|
|
8,474
|
|
|
Other expense (income), net
|
|
613
|
|
|
(30
|
)
|
|
583
|
|
|
Total segment operating income
|
|
4,283
|
|
|
358
|
|
|
4,641
|
|
|
|
Depreciation and amortization
|
|
8,189
|
|
|
-
|
|
|
8,189
|
|
|
|
Stock-based compensation
|
|
2,104
|
|
|
-
|
|
|
2,104
|
|
|
|
Equipment start-up costs(a) |
|
730
|
|
|
-
|
|
|
730
|
|
|
|
Costs related to Value Creation Plan(b) |
|
300
|
|
|
-
|
|
|
300
|
|
|
|
Recovery of product withdrawal costs(c) |
|
(1,200
|
)
|
|
-
|
|
|
(1,200
|
)
|
|
Adjusted EBITDA
|
|
14,406
|
|
|
358
|
|
|
14,764
|
|
|
|
|
|
|
|
|
|
|
|
|
|
July 1, 2017 |
|
|
|
|
|
|
|
Net loss
|
|
1,305
|
|
|
(1,407
|
)
|
|
(102
|
)
|
|
Recovery of income taxes
|
|
(4,681
|
)
|
|
(900
|
)
|
|
(5,581
|
)
|
|
Interest expense, net
|
|
7,695
|
|
|
-
|
|
|
7,695
|
|
|
Other expense, net
|
|
607
|
|
|
-
|
|
|
607
|
|
|
Total segment operating income (loss)
|
|
4,926
|
|
|
(2,307
|
)
|
|
2,619
|
|
|
|
Depreciation and amortization
|
|
7,941
|
|
|
226
|
|
|
8,167
|
|
|
|
Stock-based compensation(d) |
|
1,337
|
|
|
-
|
|
|
1,337
|
|
|
|
Costs related to Value Creation Plan(b) |
|
7,263
|
|
|
-
|
|
|
7,263
|
|
|
Adjusted EBITDA
|
|
21,467
|
|
|
(2,081
|
)
|
|
19,386
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
|
|
|
Reflects costs related to the start-up of new roasting equipment,
which were recorded in cost of goods sold.
|
(b)
|
|
|
|
For the second quarter of 2018, reflects professional fees of $0.3
million recorded in SG&A expenses. For the second quarter of 2017,
reflects facility closure costs of $0.3 million recorded in cost of
goods sold and consulting fees, temporary labor, employee
recruitment, relocation and retention costs of $7.0 million recorded
in SG&A expenses.
|
(c)
|
|
|
|
Reflects the recovery from a third-party supplier of $1.2 million of
costs we incurred relating to the withdrawal of certain
consumer-packaged products due to quality-related issues, which was
recorded in cost of goods sold. Costs incurred related to this
withdrawal were recognized in cost of goods sold in the fourth
quarter of 2016.
|
(d)
|
|
|
|
For the second quarter of 2017, stock-based compensation of $1.3
million was recorded in SG&A expenses. The reversal of $0.1 million
of previously recognized stock-based compensation, related to
forfeited awards of employees that were terminated in connection
with the Value Creation Plan, was recognized in other expense.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Excluding flexible resealable pouch and nutrition bar
|
|
Flexible resealable pouch and nutrition bar
|
|
Consolidated
|
|
For the two quarters ended |
|
$
|
|
$
|
|
$
|
|
June 30, 2018 |
|
|
|
|
|
|
|
Net loss
|
|
(6,891
|
)
|
|
(697
|
)
|
|
(7,588
|
)
|
|
Recovery of income taxes
|
|
(2,738
|
)
|
|
(245
|
)
|
|
(2,983
|
)
|
|
Interest expense, net
|
|
16,694
|
|
|
-
|
|
|
16,694
|
|
|
Other expense (income), net
|
|
(1,000
|
)
|
|
1,181
|
|
|
181
|
|
|
Total segment operating income
|
|
6,065
|
|
|
239
|
|
|
6,304
|
|
|
|
Depreciation and amortization
|
|
16,330
|
|
|
-
|
|
|
16,330
|
|
|
|
Stock-based compensation
|
|
4,275
|
|
|
-
|
|
|
4,275
|
|
|
|
Equipment start-up costs(a) |
|
730
|
|
|
-
|
|
|
730
|
|
|
|
Costs related to Value Creation Plan(b) |
|
713
|
|
|
-
|
|
|
713
|
|
|
|
Recovery of product withdrawal costs(c) |
|
(1,200
|
)
|
|
-
|
|
|
(1,200
|
)
|
|
Adjusted EBITDA
|
|
26,913
|
|
|
239
|
|
|
27,152
|
|
|
|
|
|
|
|
|
|
|
|
|
|
July 1, 2017 |
|
|
|
|
|
|
|
Net loss
|
|
(8,665
|
)
|
|
(2,621
|
)
|
|
(11,286
|
)
|
|
Recovery of income taxes
|
|
(8,875
|
)
|
|
(1,675
|
)
|
|
(10,550
|
)
|
|
Interest expense, net
|
|
15,449
|
|
|
-
|
|
|
15,449
|
|
|
Other expense, net
|
|
6,050
|
|
|
-
|
|
|
6,050
|
|
|
Total segment operating income (loss)
|
|
3,959
|
|
|
(4,296
|
)
|
|
(337
|
)
|
|
|
Depreciation and amortization
|
|
15,896
|
|
|
451
|
|
|
16,347
|
|
|
|
Stock-based compensation(d) |
|
2,465
|
|
|
-
|
|
|
2,465
|
|
|
|
Costs related to Value Creation Plan(b) |
|
19,073
|
|
|
-
|
|
|
19,073
|
|
|
|
Product withdrawal and recall costs(e) |
|
729
|
|
|
-
|
|
|
729
|
|
|
Adjusted EBITDA
|
|
42,122
|
|
|
(3,845
|
)
|
|
38,277
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
|
|
|
Reflects costs related to the start-up of new roasting equipment,
which were recorded in cost of goods sold.
|
(b)
|
|
|
|
For the first half of 2018, reflects the write-down of remaining
flexible resealable pouch and nutrition bar inventories of $0.1
million recorded in cost of goods sold; and professional and
consulting fees, and employee recruitment and relocation costs of
$0.6 million recorded in SG&A expenses. For the first half of 2017,
reflects facility closure costs of $0.6 million recorded in cost of
goods sold and consulting fees, temporary labor, employee
recruitment, relocation and retention costs of $18.4 million
recorded in SG&A expenses.
|
(c)
|
|
|
|
Reflects the recovery from a third-party supplier of $1.2 million of
costs we incurred relating to the withdrawal of certain
consumer-packaged products due to quality-related issues, which was
recorded in cost of goods sold. Costs incurred related to this
withdrawal were recognized in cost of goods sold in the fourth
quarter of 2016.
|
(d)
|
|
|
|
For the first half of 2017, stock-based compensation of $2.5 million
was recorded in SG&A expenses. The reversal of $0.3 million of
previously recognized stock-based compensation, related to forfeited
awards of employees that were terminated in connection with the
Value Creation Plan, was recognized in other expense.
|
(e)
|
|
|
|
Reflects the estimated lost gross profit caused by the recall of
certain sunflower kernel products of $0.7 million, which reflected
the shortfall in revenues in the first quarter of 2017 against first
quarter 2016 volumes of approximately $3.3 million, less associated
cost of goods sold of approximately $2.6 million.
|
|
|
|
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20180808005203/en/
Source: SunOpta Inc.
for SunOpta Inc.
Scott Van Winkle, 617-956-6736
ICR
scott.vanwinkle@icrinc.com